Drug profile · INN
vardenafil
LEVITRA
vardenafil (LEVITRA) is a phosphodiesterase 5a inhibitor.
EMA: approved Genito-urinary system and sex hormones (G04) G04BE09
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — vardenafil
- Class
- Genito-urinary system and sex hormones (G04)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
vardenafil (LEVITRA) is a phosphodiesterase 5a inhibitor.
Key facts
INN vardenafil
Brand LEVITRA
Mechanism Phosphodiesterase 5A inhibitor
Therapeutic class Genito-urinary system and sex hormones (G04)
ATC code G04BE09
Mechanism of action
Phosphodiesterase 5A inhibitor
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is vardenafil?
vardenafil (LEVITRA) is a phosphodiesterase 5a inhibitor.
What is the brand name for vardenafil?
LEVITRA is a marketed brand name for vardenafil. Check FDA Drugs@FDA for the current US label holder and prescribing information.